Four years on from the devastating Lismore floods the disaster recovery program that followed is being wound down. Hundreds of millions of dollars have been spent on a house buyback program. And while ...
Pentagon's OPEN program to help set China-free minerals prices Four critical minerals to be AI model's first focus Program aims to help offset Chinese market interference Questions on how tariffs ...
Companies in the 8(a) small business contracting program are facing unprecedented pressure as the Trump administration paints it as rife with corruption and a bastion of illegal diversity, equity, and ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...
– Vir Biotechnology (VIR) to receive EUR 55 million initial reimbursement payment upon closing, and up to EUR 495 million in clinical, regulatory and sales milestones, along with tiered, mid-teen to ...
ST. LOUIS —When Lionel Banks arrived at Missouri Baptist University, he just wanted a chance. He wasn’t the tallest running back. He wasn’t heavily recruited. But Banks has rushed his way into school ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. If you’ve ever searched for information online about the ...
The code generated by large language models (LLMs) has improved some over time — with more modern LLMs producing code that has a greater chance of compiling — but at the same time, it's stagnating in ...
First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results